Literature DB >> 19348553

Moving influenza vaccines forward.

Suryaprakash Sambhara, Iain Stephenson.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19348553     DOI： 10.1586/erv.09.10

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  4 in total

1.  Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.

Authors:  Jae-Min Song; Chi-Won Choi; Sang-Oh Kwon; Richard W Compans; Sang-Moo Kang; Seung Il Kim
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

2.  Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.

Authors:  Yanwu Li; Arundutt Silamkoti; Gundurao Kolavi; Liyuan Mou; Shelly Gulati; Gillian M Air; Wayne J Brouillette
Journal:  Bioorg Med Chem       Date:  2012-05-17       Impact factor: 3.641

3.  Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus.

Authors:  Chia-Ying Wu; Yi-Chun Yeh; Yu-Chih Yang; Ching Chou; Ming-Tsan Liu; Ho-Sheng Wu; Jia-Tsrong Chan; Pei-Wen Hsiao
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

4.  Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.

Authors:  Baoying Huang; Wenling Wang; Renqing Li; Xiuping Wang; Tao Jiang; Xiangrong Qi; Yingying Gao; Wenjie Tan; Li Ruan
Journal:  Virol J       Date:  2012-12-29       Impact factor: 4.099
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.